Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
286 hedge funds and large institutions have $1.08B invested in Avanos Medical in 2026 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 58 increasing their positions, 70 reducing their positions, and 49 closing their positions.
171% more call options, than puts
Call options by funds: $8.36M | Put options by funds: $3.09M
71% more capital invested
Capital invested by funds: $631M → $1.08B (+$451M)
61% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 49
10% more funds holding
Funds holding: 259 → 286 (+27)
3.67% less ownership
Funds ownership: 96.78% → 93.11% (-3.7%)
17% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 70
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
+$51M |
| 2 |
TAL
TIG Advisors LLC
New York
|
+$39.1M |
| 3 |
Millennium Management
New York
|
+$35.4M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$27.7M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$74.7M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$47.7M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
-$31.3M |
| 4 |
AC
Armistice Capital
New York
|
-$28M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$17M |
AVNS Hedge Fund Activity: Q2 2026 in Review
286 of the 8,329 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2026, worth a combined $1.08B — up 71% from $631M a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new AVNS positions and 49 closed out — a net gain of 30 holders — while 58 added to existing stakes and 70 trimmed.
The largest buyer was Nexpoint Asset Management, opening a new position worth an estimated $51M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $74.7M sold.
- 286 institutional investors held Avanos Medical (AVNS) as of Q2 2026, up from 259 in Q1 2026.
- Funds reported $1.08B of Avanos Medical stock for Q2 2026, up 71% quarter-over-quarter.
- 79 funds opened new Avanos Medical positions in Q2 2026 and 49 closed out, a net change of +30 holders.
- The largest Avanos Medical buyer in Q2 2026 was Nexpoint Asset Management, an estimated $51M added.
- The largest Avanos Medical seller in Q2 2026 was T. Rowe Price Investment Management, an estimated $74.7M sold.
Based on aggregated 13F filings for Q2 2026.